Swedish Orphan Biovitrum AB (publ) - Laporan Laba Rugi (TTM)

Swedish Orphan Biovitrum AB (publ)
IT ˙ BIT ˙ SE0000872095
€ 26.52 0.00 (0.00%)
2025-09-05
BAHAGING PRESYO
Laporan Laba Rugi (TTM)

Laporan Laba Rugi Swedish Orphan Biovitrum AB (publ) menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 15,570 15,261 14,283 14,424 15,214 15,529 16,793 17,458 17,696 18,790 19,104 20,100 21,270 22,123 23,140 23,710 25,435 26,027 26,236 26,970
Change (%) -1.98 -6.41 0.99 5.48 2.07 8.14 3.96 1.36 6.18 1.67 5.21 5.82 4.01 4.60 2.46 7.28 2.33 0.80 2.80
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 3,403 3,225 2,909 3,004 3,331 3,484 3,914 4,148 4,121 4,413 4,324 4,701 4,904 4,963 5,417 5,300 5,442 5,717 5,693 5,811
Change (%) -5.23 -9.80 3.27 10.89 4.59 12.34 5.98 -0.65 7.09 -2.02 8.72 4.32 1.20 9.15 -2.16 2.68 5.05 -0.42 2.07
% of Revenue 21.86 21.13 20.37 20.83 21.89 22.44 23.31 23.76 23.29 23.49 22.63 23.39 23.06 22.43 23.41 22.35 21.40 21.97 21.70 21.55
Gross Operating Profit 12,167 12,036 11,374 11,420 11,883 12,045 12,879 13,310 13,575 14,377 14,780 15,399 16,366 17,160 17,723 18,410 19,993 20,310 20,543 21,159
Change (%) -1.08 -5.50 0.40 4.05 1.36 6.92 3.35 1.99 5.91 2.80 4.19 6.28 4.85 3.28 3.88 8.60 1.59 1.15 3.00
% of Revenue 78.14 78.87 79.63 79.17 78.11 77.56 76.69 76.24 76.71 76.51 77.37 76.61 76.94 77.57 76.59 77.65 78.60 78.03 78.30 78.45
SG&A 5,894 5,981 5,876 5,868 6,022 6,294 6,667 7,077 7,340 7,637 7,859 8,202 8,947 9,773 10,201 10,609 10,725 10,967 11,192 11,298
Change (%) 1.48 -1.76 -0.14 2.62 4.52 5.93 6.15 3.72 4.05 2.91 4.36 9.08 9.23 4.38 4.00 1.09 2.26 2.05 0.95
% of Revenue 37.85 39.19 41.14 40.68 39.58 40.53 39.70 40.54 41.48 40.64 41.14 40.81 42.06 44.18 44.08 44.74 42.17 42.14 42.66 41.89
R&D 1,418 1,594 1,706 1,845 1,926 1,987 2,042 2,116 2,156 2,252 2,371 2,358 2,594 2,743 2,903 3,257 3,340 3,529 3,558 3,443
Change (%) 12.41 7.03 8.15 4.39 3.17 2.77 3.62 1.89 4.45 5.28 -0.55 10.01 5.74 5.83 12.19 2.55 5.66 0.82 -3.23
% of Revenue 9.11 10.44 11.94 12.79 12.66 12.80 12.16 12.12 12.18 11.99 12.41 11.73 12.20 12.40 12.55 13.74 13.13 13.56 13.56 12.77
OpEx 10,829 10,798 10,484 10,700 11,246 11,735 12,595 13,291 13,537 14,270 14,527 15,308 16,529 17,470 18,513 19,094 19,375 20,204 20,432 20,560
Change (%) -0.29 -2.91 2.06 5.10 4.35 7.33 5.53 1.85 5.41 1.80 5.38 7.98 5.69 5.97 3.14 1.47 4.28 1.13 0.63
% of Revenue 69.55 70.76 73.40 74.18 73.92 75.57 75.00 76.13 76.50 75.94 76.04 76.16 77.71 78.97 80.00 80.53 76.17 77.63 77.88 76.23
Operating Income 4,741 4,463 3,799 3,724 3,968 3,794 4,198 4,167 4,159 4,520 4,577 4,792 4,741 4,653 4,627 4,616 6,060 5,823 5,804 6,410
Change (%) -5.86 -14.88 -1.97 6.55 -4.39 10.65 -0.74 -0.19 8.68 1.26 4.70 -1.06 -1.86 -0.56 -0.24 31.28 -3.91 -0.33 10.44
% of Revenue 30.45 29.24 26.60 25.82 26.08 24.43 25.00 23.87 23.50 24.06 23.96 23.84 22.29 21.03 20.00 19.47 23.83 22.37 22.12 23.77
Interest Expense -512 -454 -428 -357 -369 -419 -406 -399 -425 -458 -526 -559 -855 -1,111 -1,272 -1,471 -1,366 -1,239 -1,170 -1,049
Change (%) -11.33 -5.73 -16.59 3.36 13.55 -3.10 -1.72 6.52 7.76 14.85 6.27 52.95 29.94 14.49 15.64 -7.14 -9.30 -5.57 -10.34
% of Revenue -3.29 -2.97 -3.00 -2.48 -2.43 -2.70 -2.42 -2.29 -2.40 -2.44 -2.75 -2.78 -4.02 -5.02 -5.50 -6.20 -5.37 -4.76 -4.46 -3.89
Net Income 3,103 3,245 2,759 2,744 2,940 2,679 2,526 2,516 2,493 2,638 3,162 3,125 2,769 2,409 2,142 2,145 3,514 3,885 3,960 4,372
Change (%) 4.58 -14.98 -0.54 7.14 -8.88 -5.71 -0.40 -0.91 5.82 19.86 -1.17 -11.39 -13.00 -11.08 0.14 63.82 10.56 1.93 10.40
% of Revenue 19.93 21.26 19.32 19.02 19.32 17.25 15.04 14.41 14.09 14.04 16.55 15.55 13.02 10.89 9.26 9.05 13.82 14.93 15.09 16.21

Source: Capital IQ

Other Listings
GB:SOBIS
US:BIOVF
GB:0MTD SEK 275.20
SE:SOBI SEK 283.00
DE:B6E € 24.80
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista